Search

Ascenion’s Annual Review 2023/24: From spin-off to exit

Spin-offs, start-ups, inventions from research institutes and universities – all these help to secure Germany’s leading economic position. Read more about start-ups, and the part we play in them, in our Annual Review.

Early this year we experienced an exceptional event in the German start-up scene, with Cardior’s billion-euro exit. Success stories like these motivate the Hannover Medical School (MHH) and other research institutes to carry on patenting good ideas and supporting inventors, entrepreneurs and their spin-offs – because the institutes participate fairly in the value creation process.

Happily, Ascenion’s portfolio is successfully bucking the trend this year, with around one new start-up launched each month. Our success rate in attracting venture capital and partners is also well above average. This shows that, together, research institutes and their technology transfer partners can achieve a great deal when they provide professional support for their start-ups and align licensing and equity agreements with the demands of the market.

You can read more about start-ups and our collaborations over the past year in our Annual Review. We wish you an enjoyable and inspiring read!

Ascenion’s Annual Review 2023/2024